Today, more than half of patients diagnosed with advanced melanoma and treated with new therapies are alive five years after diagnosis.

Artificial intelligence (AI) can be used as a tool to help detect melanoma and other skin cancers earlier. But challenges remain.

The topical cream Opzulera (ruxolitinib) can improv skin repigmentation in people with melanoma-associated vitiligo.

Damon Runyon researchers outfitted T cells with a mutated cytokine receptor, enabling them to attack melanoma and pancreatic cancer.

The approach appears to benefit people with advanced forms of the disease but whose cancer can still be treated with surgery.

Most melanomas—a series type of skin cancer—are caused by exposure to the sun’s UV rays. But can eating fish also contribute to risk?

Researchers have recently made progress in understanding what causes some types of resistance to immunotherapies.

Firefighting has long been linked to cancer, especially mesothelioma and other cancers of the lungs.

Patients treated with tumor-infiltrating lymphocytes saw a 50% reduction in disease progression or death.

May is National Melanoma/Skin Cancer Detection and Prevention Month.